expert review of clinical pharmacology

Stem cell research

the eurasian journal of medicine

world journal of gastroenterology

Cancer medicine

avicenna journal of medical biotechnology

[1] Cytokines, cytokine gene polymorphisms and Helicobacter pylori infection: friend or foe?

[2] Construction, Cloning, and Expression of CagA Recombinant Protein of .

[3] Clarithromycin Versus Metronidazole in First-Line Helicobacter Pylori Triple Eradication Therapy Based on Resistance to Antimicrobial Agents: Meta-Analysis

[4] Antibiotic Resistance and Therapy for H. pylori Infection in Immigrant Patients Treated in Italy

[5] Active Helicobacter pylori Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients

[6] Active Helicobacter pylori Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients

[7] The Impact of Gastric Juice pH on the Intraluminal Therapy for Helicobacter pylori Infection

[8] Genotypic and Phenotypic Resistance to Clarithromycin in Helicobacter pylori Strains

[9] antibiotic resistance in helicobacter pylori: a mutational analysis from a tertiary care hospital in kashmir, india

[10] epidemiology of helicobacter pylori and caga-positive infections and global variations in gastric cancer

[11] do probiotic preparations for humans really have efficacy?

[12] cage as a biomarker of the pathogenicity of helicobacter pylori

[13] helicobacter pylori seropositivity in patients with hyperemesis gravidarum in lakes region

[14] protease activity of helicobacter pylori strains and their association with histopathological changes of the gastric tissue

[15] helicobacter pylori genetic diversification in the mongolian gerbil model

[16] helicobacter pylori and cardiovascular complications: a mechanism based review on role of helicobacter pylori in cardiovascular diseases

[17] influence of intestinal indigenous microbiota on intrafamilial infection by helicobacter pylori in japan

[18] caracterización de los pacientes infectados por helicobacter pylori durante un trienio

[19] recommendations for endoscopic and histological follow-up of patients with chronic gastritis and precancerous gastric lesions

[20] detouring the undesired route of helicobacter pylori-induced gastric carcinogenesis

[21] in vitro incorporation of <i>helicobacter pylori</i> into <i>candida albicans</i> caused by acidic ph stress

[22] food bioactive components, a possible adjuvant for h. pylori eradication

[23] an update on helicobacter pylori in pediatrics

[24] evidence of mother-child transmission of helicobacter pylori infection evidência da transmissão mãe-filho da infecção por helicobacter pylori

[25] helicobacter pylori: su importancia como problema de salud en la comunidad

[26] helicobacter pylori infection is not associated with failure to thrive: a case&ndash;control study

[27] the relation between severe density of helicobacter pylori in biopsy with cigarette smoking and age in infected patients

[28] a low cost method to produce a gaseous environment for the isolation of helicobacter pylori un método de bajo costo para producir el ambiente gaseoso para el aislamiento de helicobacter pylori

[29] mucoadhesive microparticulate drug delivery system of curcumin against helicobacter pylori infection: design, development and optimization

[30] can probiotics improve efficiency and safety profile of triple helicobacter pylori eradication therapy? a prospective randomized study

[31] gastric angiogenesis and helicobacter pylori infection angiogénesis gástrica e infección por helicobacter pylori

[32] modern problems of treatment of helicobacter-associated diseases in children: opportunities of adjuvant therapy

[33] prevalence of the helicobacter pylori in the tonsils and adenoids

[34] identification of helicobacter pylori dna in gallstones using multiplex pcr

[35] performance of a one-step fecal sample-based test for diagnosis of helicobacter pylori infection in primary care and mass screening settings

[36] asociación del polimorfismo del codon 72 del gen p53 con el riesgo de cáncer gástrico en una población de alto riesgo de costa rica

[37] allergies, helicobacter pylori and the continental enigmas

[38] primary bile reflux gastritis versus helicobacter pylori gastritis: a comparative study

[39] comparison of histological and molecular diagnosis of helicobacter pylori in benign lesions and gastric adenocarcinoma comparação dos diagnósticos histológico e molecular do helicobacter pylori em lesões benignas e adenocarcinomas gástricos

[40] helicobacter, hygiene, atopy, and asthma

[41] role and importance of microbiology testing in the diagnosis and treatment of helicobacter pylori infection.

[42] dispepsia funcional y dispepsia asociada a infección por helicobacter pylori: ¿son entidades con características clínicas diferentes?

[43] eradication therapy for urticaria with high titers of anti h. pylori igg antibody

[44] helicobacter pylori caga: from pathogenic mechanisms to its use as an anti-cancer vaccine

[45] antimicrobial resistance of helicobacter pylori strains to five antibiotics, including levofloxacin, in northwestern turkey

[46] helicobacter pylori: recent advances in the study of its pathogenicity and prevention

[47] asociación entre gastritis folicular y helicobacter pylori en niños atendidos en un hospital público peruano

[48] duodenal nodularity in children: a clinical and pathologic study of 17 cases

[49] remodeling the host environment: modulation of the gastric epithelium by the helicobacter pylori vacuolating toxin (vaca)

[50] caracterización de pacientes con sangramiento digestivo alto characterization of patients presenting with high digestive bleeding

[51] helicobacter pylori serology in relation to hepatitis c virus infection and il28b single nucleotide polymorphism

[52] disrupted human-pathogen co-evolution: a model for disease

[53] spanish scientific output on helicobacter pylori: a study through medline producción científica española relacionada con helicobacter pylori: un estudio a través de medline

[54] Úlcera péptica gastroduodenal e infecção pelo helicobacter pylori na criança e adolescente gastroduodenal peptic ulcer and helicobacter pylori infection in children and adolescents

[55] investigation of the association between clinical outcome and the cag pathogenicity-island and other virulence genes of helicobacter pylori isolates from patients with dyspepsia in eastern turkey

[56] proteomics analysis revealed that crosstalk between helicobacter pylori and streptococcus mitis may enhance bacterial survival and reduces carcinogenesis

[57] helicobacter pylori and anemia: a community-based cross-sectional study among adults in southern brazil helicobacter pylori e anemia: um estudo transversal de base populacional entre adultos no sul do brasil

[58] Gene silencing of Helicobacter pylori through newly designed siRNA convenes the treatment of gastric cancer.

[59] Antimicrobial activity of Southern African medicinal plants on Helicobacter pylori and Lactobacillus species.

[60] Anti-helicobacter pylori activities of shoya powder and essential oils of thymus vulgaris and eucalyptus globulus

[61] Simvastatin improves the eradication rate of Helicobacter pylori: upper Egypt experience

[62] First-line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus

[63] Increase in antibiotic resistant Helicobacter pylori in a University Hospital in Japan

[64] Genetic basis for metronidazole and clarithromycin resistance in&nbsp;Helicobacter pylori&nbsp;strains isolated from patients with gastroduodenal disorders

[65] Alternative eradication regimens for Helicobacter pylori infection in Indonesian regions with high metronidazole and levofloxacin resistance

[66] Genotyping and antibiotic resistance properties of Helicobacter pylori strains isolated from human and animal gastric biopsies

[67] Efficacy of a 14-day quadruple-therapy regimen for third-line Helicobacter pylori eradication

[68] Current eradication rate of Helicobacter pylori with clarithromycin-based triple therapy in a gastroenterology practice in the New York metropolitan area

[69] Antibiotic resistance among Helicobacter pylori clinical isolates in Lima, Peru

[70] Probiotics improve the efficacy of standard triple therapy in the eradication of Helicobacter pylori: a meta-analysis

[71] Simvastatin improves the eradication rate of Helicobacter pylori: upper Egypt experience

[72] First-line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus

[73] Simvastatin improves the eradication rate of Helicobacter pylori: upper Egypt experience

[74] First-line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus

[75] Immunization with a Synthetic Helicobacter pylori Peptide Induces Secretory IgA Antibodies and Protects Mice against Infection

[76] Increase in antibiotic resistant Helicobacter pylori in a University Hospital in Japan

[77] Genetic basis for metronidazole and clarithromycin resistance in&nbsp;Helicobacter pylori&nbsp;strains isolated from patients with gastroduodenal disorders

[78] Alternative eradication regimens for Helicobacter pylori infection in Indonesian regions with high metronidazole and levofloxacin resistance

[79] Genotyping and antibiotic resistance properties of Helicobacter pylori strains isolated from human and animal gastric biopsies

[80] Efficacy of a 14-day quadruple-therapy regimen for third-line Helicobacter pylori eradication

[81] Current eradication rate of Helicobacter pylori with clarithromycin-based triple therapy in a gastroenterology practice in the New York metropolitan area

[82] Antibiotic resistance among Helicobacter pylori clinical isolates in Lima, Peru

[83] Probiotics improve the efficacy of standard triple therapy in the eradication of Helicobacter pylori: a meta-analysis

[84] The Contribution of Drugs and Helicobacter pylori to Gastric Mucosa Changes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome

[85] Role of Probiotics in Helicobacter pylori Eradication: Lessons from a Study of Lactobacillus reuteri Strains DSM 17938 and ATCC PTA 6475 (Gastrus®) and a Proton-Pump Inhibitor

[86] [Level of Helicobacter pylori infection of the gastric mucosa in the optimization of a daily dose of antihelicobacter drugs].

[87] Chemical Constituents of Cymbocarpum erythraeum (DC.) Boiss., and Evaluation of Its Anti-Helicobacter pylori Activity

[88] Evidence of the gastroprotective and anti-Helicobacter pylori activities of &beta;-mangostin isolated from Cratoxylum arborescens (vahl) blume

[89] Anti-Helicobacter pylori and antiulcerogenic activity of Aframomum pruinosum seeds on indomethacin-induced gastric ulcer in rats

[90] Synthesis and biological activity of 5-nitrofuran-containing (1,3,4-thiadiazol-2-yl)piperazine moieties as a new type of anti-Helicobacter pylori heterocycles

[91] In silico probing exercises, bioactive-conformational and dynamic simulations strategies for designing and promoting selective therapeutics against Helicobacter pylori strains.

[92] Efficacy and safety of eradication therapy for elderly patients with helicobacter pylori infection.

[93] Treatment of Helicobacter pylori.

[94] Helicobacter pylori, causation, change in natural history, and why helicobacter-positive duodenal ulcers should not be routinely treated

[95] Combined effect between WT1 methylation and Helicobacter pylori infection, smoking, and alcohol consumption on the risk of gastric cancer.

[96] Clinical features of Helicobacter pylori antibody-positive junior high school students in Nagano Prefecture, Japan.

[97] Cost-effectiveness of Helicobacter pylori screening followed by eradication treatment for employees in Japan

[98] Corrigendum: Helicobacter pylori cagA+ Is Associated with Milder Duodenal Histological Changes in Chilean Celiac Patients

[99] Detection of antimicrobial resistance genes of Helicobacter pylori strains to clarithromycin, metronidazole, amoxicillin and tetracycline among Egyptian patients

[100] Reverse Hybrid Therapy Achieves a Similar Eradication Rate as Standard Hybrid Therapy for Helicobacter Pylori Infection.

[101] Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori